Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy

G M Felker1, R E Thompson, J M Hare

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Insights

Identifying the specific cause of cardiomyopathy significantly impacts patient prognosis. Peripartum cardiomyopathy offers a better outlook, while infiltrative diseases, HIV, and doxorubicin therapy indicate a poorer prognosis for heart failure patients.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Prognostic Biomarkers

Background:

  • Previous heart failure prognosis studies focused on ischemic vs. non-ischemic cardiomyopathy.
  • The prognostic significance of specific underlying causes of cardiomyopathy remains largely unknown.

Purpose of the Study:

  • To investigate the prognostic value of specific etiologies in patients with cardiomyopathy.
  • To compare survival rates across different causes of cardiomyopathy.

Main Methods:

  • Evaluated outcomes of 1230 cardiomyopathy patients categorized by cause.
  • Utilized Cox proportional-hazards analysis to assess survival associations.
  • Included causes such as idiopathic, peripartum, myocarditis, ischemic heart disease, HIV, and doxorubicin therapy.

Main Results:

  • Survival varied significantly based on cardiomyopathy cause over a 4.4-year follow-up.
  • Peripartum cardiomyopathy showed better survival (HR 0.31) compared to idiopathic.
  • Worse survival observed in infiltrative myocardial disease (HR 4.40), HIV infection (HR 5.86), doxorubicin therapy (HR 3.46), and ischemic heart disease (HR 1.52).

Conclusions:

  • The specific cause of cardiomyopathy is a crucial prognostic factor for heart failure.
  • Peripartum cardiomyopathy is associated with a favorable prognosis.
  • Infiltrative myocardial diseases, HIV infection, and doxorubicin treatment confer a particularly poor prognosis.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...